Santo Domingo, RD.
The various agreements that have held the dominant government with pharmaceutical companies, set up to develop vacancies against the pandemic of covid-19 allow the countries to access 20 million doses, according to Estado.
Los montos están divididos de la siguiente manera: 10 millone de dosage con Astrazeneca, 8 millones met Pfizer-BioNTech en 2 millones met Covax, dit is a global mechanism of the Organización Mundial de la Salud (OMS) for the guarantee of a worldwide an equitable access to the vacancies.
Last Thursday, October 30, the Dominican Governor agreed with the British biopharmaceutical company AstraZeneca to acquire 10 million doses of its vaccine AZD1222, developed together with the University of Oxford.
The total inversion will be 40 million dollars, four dollars per vacancy. The first payment of 8 million dollars will be supported by the private sector.
While 15 years ago, the Vice President of the Republic, Raquel Peña, announced that the governing body had agreed with the pharmaceuticals Pfizer and BioNTech that 7.9 million doses of the BNT162b2 vaccine were available, against Covid-19.
According to Luis Abinader’s Gobierno, these doses are defined by phases of the “characteristics of the high priority groups, the volume and periodicity of vacancy rates, the position and promotion of vacancies” .
Formerly, Gobierno informs that it hopes that by December 7 101 043 people aged 18 to 80 years will have received the dose “depending on the situation of the nurse who is in the wake of the sanitary emergency”.
The phases will be defined in accordance with the characteristics of the groups of risk priorities, the volume and periodicity of vacancy rates, the position and promotion of vacancies in the population, among other important aspects. pic.twitter.com/mVB3ndlRwJ
– ComunicacionesRD (@Comunicaciondo) 22 January 2021